Health Care: Drugs

Apricus Biosciences Inc (APRI: NASDAQ)

$1.14 n/a | n/a%
12/09/16 - 04:00 PM ET
Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -19.02M -21.79M -16.94M -31.77M
Operating Gains/Losses 102.00K 4.15M -1.43M -250.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 159.00K -620.00K 253.00K 682.00K
(Increase) Decrease in Inventories -194.00K 61.00K -341.00K 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 609.00K -66.00K -920.00K 681.00K
(Decrease) Increase In Other Current Liabilities -1.17M 2.62M -616.00K -381.00K
(Increase) Decrease In Other Working Capital -1.25M -2.79M 712.00K -493.00K
Other Non-Cash Items -1.98M 1.20M 5.36M 18.30M
Net Cash From Continuing Operations -22.64M -17.36M -13.45M -12.70M
Net Cash From Discontinued Operations 0.00 16.00K 38.00K -1.99M
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -22.64M -17.34M -13.41M -14.68M
Sale of Property, Plant & Equipment 5.00K 0.00 3.66M 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment 0.00 0.00 0.00 -436.00K
Acquisitions 0.00 50.00K 255.00K 1.80M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -337.00K -1.25M -2.50M 300.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -332.00K -530.00K 3.06M 1.37M
Issuance of Debt 5.00M 4.73M 0.00 3.41M
Cash Used for Financing Activities
Issuance of Capital Stock 10.95M 5.91M 16.66M 20.46M
Repayment of Long-Term Debt -501.00K -2.78M -27.00K -4.01M
Repurchase of Capital Stock 0.00 -42.00K 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 10.00K 42.00K 0.00 906.00K
Net Cash From Financing Activities 15.46M 7.87M 16.63M 20.77M
Effect of Exchange Rate Changes 0.00 0.00 0.00 243.00K
Net Change in Cash & Cash Equivalents -7.51M -10.01M 6.28M 7.70M

Portfolios with APRI

Latest APRI Headlines from TheStreet

More Financial News for APRI

Press Releases for APRI

See All Press Releases

Partner Headlines for APRI

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter